Almanac A1C

Your Cells’ Secret Housekeeping System: How ‘Self-Eating’ Autophagy Could Hold the Key to Longer, Healthier Life

Posted

by

A1C Medical Writer 2

Table of Contents
Keywords: , ,

Introduction

Autophagy, derived from the Greek terms for “self-eating,” represents one of the most fundamental cellular maintenance mechanisms in eukaryotic cells. This highly conserved process involves the lysosomal degradation of cellular components, including damaged organelles, misfolded proteins, and other cellular debris. Its careful regulation is intertwined with metabolic health and underpins cellular adaptation to energy fluctuations, impacting disease prevention and the aging process. This paper examines the metabolic regulation of autophagy and its implications for health and longevity, incorporating the latest research findings [1-3].

Basic Mechanisms and Functions of Autophagy

Autophagy is a highly conserved cellular process by which cells degrade and recycle their own components- such as proteins, lipid droplets, and damaged organelles-through lysosome-mediated pathways. This process is crucial for maintaining cellular homeostasis especially under stress conditions, such as nutrient deprivation, hypoxia or infection [4]. It encompasses three main types: macroautophagy (commonly referred to simply as “autophagy”), microautophagy, and chaperone-mediated autophagy (CMA). All three types coexist in mammalian cells and can compensate for each other when one is impaired, though evidence suggests their interplay is complex and context-dependent [5].

Macroautophagy involves the formation of double-membrane vesicles (autophagosomes) that engulf cytoplasmic components before fusing with lysosomes for degradation [5]. These are the steps of macroautophagy:

  • Initiation : Triggered by signals such as nutrient starvation, inhibition of mechanistic target of rapamycin (mTOR), or activation of AMP-activated protein kinase (AMPK) [6,7].
  • Phagophore Formation: A membrane structure (phagophore) forms, supported by protein complexes, notably ULK1 and PI3K complexes (involving Atg proteins, Beclin1, Vps34, Vps15) [4,7,8].
  • Expansion and Completion : The phagophore elongates and encloses cytoplasmic cargo, forming a mature autophagosome, a doubled- membraned vesicle [7,8].
  • Fusion and Degradation : The autophagosome fuses with the lysosome to form and autolysosome, where the cargo is degraded, and resulting biomolecules are recycled back into cytoplasm [7].

So what is the functions of autophagy. These are the functions:

  • Cellular Quality Control : Removes dysfunctional or damages organelles and proteins, preventing cellular damage and contributing to longevity and disease prevention [9].
  • Energy and Nutrient Supply: During starvation or stress, autophagy provides essential biomolecules by degrading and recycling intracellular components, ensuring cellular survival [6,10,11].
  • Metabolic Regulation: Plays a role in regulating lipid and glucose metabolism, contributing to metabolic homeostasis and prevention of metabolic diseases [2,10,12].
  • Immune Defense : Eliminates intracellular pathogens and participates in innate and adaptive immunity by degrading bacteria, viruses, and presenting antigens [13].
  • Cell Death and Survival : Balances cell survival and programmed cell death; excessive or defective autophagy is implicated in diseases such as neurodegeneration, cancer, and metabolic disorders [7,14].
  • Development and Differentiation: Participates in normal development and cells differentiation by clearing unnecessary components[14].
StepMajor Proteins InvolvedCore Function
InitiationmTOR, AMPK, ULK1 complexSenses cellular energy/nutrient status
NucleationBeclin1, Vps34, Atg14, Vps15Forms phagophore/isolation membrane
Elongation & ClosureAtg5-Atg12, LC3/Atg8, WIPI2Engulfs cytoplasmic cargo, forms autophagosome
Fusion with LysosomeSTX17, SNAP29, HOPSForms autolysosome, begins cargo degradation
Cargo DegradationLysosomal hydrolasesRecycle biomolecules
Table 1. Key Steps in Autophagy

Metabolic Regulation of Autophagy

Autophagy is tightly regulated by the metabolic state of the cell, responding to nutrient levels, energy status, hormonal cues, and stress. These regulatory networks ensure autophagy is activated when cells need to adapt to metabolic stress or nutrient deprivation and suppressed during of abundance.

  • Central Regulators: mTOR and AMPK [15-18] The mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) function as the primary upstream regulators of autophagy, integrating various metabolic signals to control autophagic activity. mTOR complex 1 (mTORC1) inhibits autophagy under nutrient-rich conditions by phosphorylating ULK1/2 and ATG13, preventing the initiation of autophagy. Additionally, mTORC1 phosphorylates the transcription factor EB (TFEB), preventing its nuclear translocation and subsequent transcription of autophagy-related genes. Conversely, AMPK activates autophagy through multiple mechanisms. During energy deficiency (high AMP/ATP ratio), AMPK phosphorylates ULK1/2 at sites that enhance its activation. Simultaneously, AMPK inhibits mTORC1, relieving its suppressive effect on autophagy. This dual mechanism ensures robust autophagy activation during energy stress.
  • Insulin Signalling and Nutrient Sensing [15] Insulin significantly influences autophagy primarily through the PI3K/AKT/mTOR signalling pathway. When insulin levels rise following carbohydrate consumption, it activates this cascade, leading to mTORC1 activation and autophagy suppression. Recent research by Liu et al. (2024) demonstrated that O-GlcNAcylation, a nutrient-sensitive post-translational modification, positively regulates mTORC1 signalling in pancreatic β-cells while negatively modulating autophagy. This finding provides novel insights into how nutrient sensing affects autophagy in β-cells and influences glucose homeostasis. In states of insulin resistance, hyperinsulinemia inhibits autophagy by activating mTOR and inhibiting fork head box O3 (FOXO3), which normally activates autophagy. This mechanism contributes to the complex relationship between metabolic disorders and autophagy dysfunction.
  • Cellular Energy Status and NAD+ Metabolism[19] Cellular energy status, reflected by the AMP/ATP ratio, is another critical regulator of autophagy. Energy depletion activates AMPK, which promotes autophagy as described above. Additionally, NAD+ levels, which decline during aging, influence autophagy through sirtuin activation. A 2023 study highlighted the bidirectional relationship between NAD+ and autophagy in longevity and disease. NAD+-dependent deacetylases like SIRT1 regulate autophagy and mitochondrial quality control, while autophagy itself helps preserve NAD+ levels by modulating cellular stress. This interconnection provides potential therapeutic targets for combating age-related diseases and promoting longevity.

Autophagy in Adipose Tissue and Metabolic Health

Adipose Tissue Autophagy

Adipose tissue (body fat) mainly includes:

  • White adipose tissue (WAT): stores energy in the form of fat
  • Brown adipose tissue (BAT): burns fat to generate heat.

Autophagy plays a distinct roles within these tissues:

  • Adipogenesis Regulation: Autophagy is key regulator of the development and function of both WAT and BAT. It supports the differentiation of preadipocytes (precursor cells) into mature adipocytes (fat cells), aiding in healthy fat accumulation [20,21].
  • Lipid Metabolism: During periods of energy demand or stress, autophagy helps release stored fats by breaking down lipid droplets within adipocytes, a process known as lipophagy [22].
  • Organelle turnover: it removes dysfunctional mitochondria and other organelles, maintaining healthy cell function [22].

Obesity and Autophagy Dysfunction

The relationship between obesity and autophagy is complex. Multiple studies indicate that obesity affects autophagy function, but the exact nature of this relationship varies by tissue and context.

A 2024 review by Kohlgruber et al. indicated that autophagy appears to be upregulated during the initiation phase of autophagosome formation in obese individuals, potentially as a compensatory response to proinflammatory conditions in adipose tissue [23]. However, studies in animal models show that autophagy markers like ATG5 and ATG7 are often downregulated in obesity, contributing to metabolic dysfunction.

High-fat diet challenges in mice result in compromised autophagic activity associated with impaired lysosomal acidification, contributing to lipotoxicity in various tissues. Interestingly, verapamil, a calcium channel blocker, has been shown to restore autophagic flux in the liver and attenuate inflammation and insulin resistance in obese mice [24].

Type 2 Diabetes and β-Cell Function

Autophagy plays a critical role in pancreatic β-cell function and insulin sensitivity. Basal autophagy preserves and protects β-cell function from oxidative stress, while dysregulated autophagy contributes to the pathophysiology of type 2 diabetes (T2D).

Recent research by Al-Kuraishy et al. (2024) characterizes autophagy as a “double-edged sword” in T2D. While basal autophagy is essential for β-cell homeostasis, excessive activation can increase apoptosis. For instance, strong activation of autophagy by rapamycin decreases insulin production and exacerbates β-cell death in some contexts [25].

Notably, many antidiabetic drugs, including metformin, rosiglitazone, and glucagon-like peptide 1 (GLP-1) agonists, prevent β-cell dysfunction by inducing balanced autophagy. These drugs increase AMPK expression, which induces autophagy by inhibiting mTORC1 or activating the Vps34 complex. This suggests that moderate autophagy enhancement could be a therapeutic strategy for T2D management.

Inflammation and Chronic Disease

In obese or diabetic individuals, altered autophagy in adipose tissue is linked with inflammation and recruitment of immune cells, impacting metabolic health by worsening chronic inflammatory states [20,28].

Modulating autophagy could serve as a target for therapies aimed at reducing inflammation and improving metabolic diseases.

FunctionImpact on Metabolic HealthNotes
Adipocyte DifferentiationPromotes healthy fat tissue development [20,21]Impaired autophagy reduces fat accumulation
Lipid Metabolism (Lipophagy)Regulates fat storage and release [12,22]Key during fasting and energy demand
Organelle Quality ControlMaintains adipocyte health [22]Removes damaged mitochondria
Inflammation modulationInfluences chronic inflammation [20,26]Affects insulin sensitivity and diabetes risk
Systemic Glucose HomeostasisSupports insulin sensitivity [22,27]Disruption leads to metabolic syndrome
Table 2. Key Roles Autophagy in Adipose Tissue

Autophagy and Longevity

How Autophagy Promotes Longevity

  • Maintaining Cellular Homeostasis: Autophagy clears out dysfunctional proteins and organelles that accumulate with age. This prevents cellular damage that is linked to aging and age-related diseases [28,29].
  • Stress Resistance: Enhanced autophagy boost cells’ ability to handle metabolic and environmental stress, providing a protective effect that contributes to increased health span and lifespan [28].
  • Mitigation of Age-Related Decline: Loss of autophagy accelerates aging phenotypes such as protein aggregation, mitochondrial dysfunction, and tissue degeneration-while upregulating autophagy can postpone or reduce these age-associated declines [29-31].
  • Tissue-Specific Effects: Activating autophagy in specific tissues, such as neurons or adipose tissue, can improve systemic health and extend organismal lifespan [28,32].

Evidence Supporting the Autophagy-Longevity Link

  • Genetic Studies: Mutations that impair autophagy genes (e.g., Atg5, Atg7,Beclin1) shorten lifespan and cause premature aging in multiple animal models. Conversely, overexpressing key autophagy genes extends life. For example, overexpression of the ATG5 gene increased mouse lifespan by 17-20% and improved metabolic and motor functions [29,30,32] .
  • Pharmacological Interventions: Drugs or interventions that induce autophagy (such as caloric restriction, rapamycin, and spermidine) are consistently associated with lifespan extension in model organism [28,32,33].
  • Evolutionary Conservation: The longevity-promoting effects of autophagy are conserved from yeast to mammals, showing it is a fundamental, evolutionarily ancient mechanism [32,34,35].
  • Mitochondrial Integrity and Autophagy: Mitochondrial dysfunction is a hallmark of aging, and mitophagy—the selective autophagy of mitochondria—plays a crucial role in maintaining mitochondrial quality control. Research has identified Cisd2 (CDGSH iron-sulphur domain-containing protein 2) as a critical factor in maintaining mitochondrial integrity and function.

A 2022 study published in the Journal of Biomedical Science demonstrated that Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice, while interventions that preserve or enhance Cisd2 function promote longevity and delay aging. These findings underscore the intimate connection between autophagy, mitochondrial health, and aging processes [36].

MechanismLongevity Impact
Removal of damaged componentsReduces cellular dysfunction that causes aging [28,29]
Protection from metabolic stressEnhances survival during nutrient scarcity or cellular stress [28,32]
Prevention of protein aggregationLower risk of neurodegenerative and age-related disease [29]
Regulation of metabolismSupports healthy metabolism, insulin sensitivity and leanness [29,32]
Table 3. Mechanism of Longevity

Modulators of Autophagy

Autophagy is a highly regulated cellular process controlled by a variety of signalling pathways, molecules, and environmental factors. Modulators of autophagy can either induce or inhibit this process, impacting cellular health, stress responses, metabolism, and disease states.

Major Classes of Autophagy Modulators

  1. Nutrient and Energy Sensing Pathways
    • mTOR (mechanistic Target of Rapamycin): When nutrients (especially amino acids) are abundant, mTOR is active and suppresses autophagy. During starvation, mTOR inhibited, which activates autophagy [37,38].
    • AMPK (AMP-activated Protein Kinase):
      • Energy sensor and positive regulator. Activated when cellular energy is low (high AMP/ATP ration), AMPK promotes autophagy by inhibiting mTOR and activating other autophagic machinery [37,38].
  2. Hormones and Growth Factors
    • Insulin and IGF-1: suppress autophagy via mTOR activation in nutrient-rich conditions [39]
    • Glucagon: induces autophagy, especially during fasting, to maintain glucose homeostasis [15]
    • Other factors: deprivation of growth factors or presence of certain cytokines can also modulate autophagy.
  3. Cellular and Environmental Stress
    • Starvation and Hypoxia: Both conditions activate autophagy to sustain cellular survival by recycling components [15,39]
    • Oxidative Stress/ROS: Reactive oxygen species can trigger autophagy as a protective mechanism
    • ER Stress & Unfolded Protein Response: Induce autophagy through signalling pathways such as PERK-elF2a and IRE1-JNK [15]
  4. Pharmacological and Chemical Modulators:
    • Inducers:
      • Rapamycin: Direct mTOR inhibitor, widely used to activate autophagy [37,40].
      • Metformin: indirectly activates AMPK, thereby inducing autophagy [37]
      • Trehalose, Spermidine, Tat-Beclin 1, Lithium: use diverse mTOR-dependent and independent mechanisms [37]
      • Phytochemicals: Plant-derived compounds (e.g., resveratrol, curcumin) can modulate autophagy through various pathways [40].
    • Inhibitors:
      • Chloroquine, Bafilomycin A1: inhibit late stages of autophagy by blocking lysosomal acidification and fusion, disrupting cargo degradation [15,39]
      • 3-Methyladenine (3-MA): blocks PI3K, an enzyme critical for autophagosome formation [ 39]
  5. Transcriptional and Epigenetic Modulation
    • TFEB (Transcription Factor EB): drives expression of autophagy and lysosomal genes, enhancing the cell’s degradative capacity [37,41].
    • FOXO Family, p53, and others: These transcription factors can upregulate or downregulate autophagy genes in response to stress or metabolic changes [39,41].
  6. Ions and Small Molecules
    • Ca2+, Nitric Oxide, Inositol: Elevations can act as negative regulators of autophagy through signalling cross-talk with mTOR-independent pathways [37].
    • Iron and amino acid depletion: induce autophagy to support cellular survival [42].
  7. Lifestyle and Environmental Factors
    • Caloric restriction: Potent activator, stimulates autophagy mainly by reducing mTOR activity and enhancing AMPK signals [43].
    • Physical exercise: shown to upregulate autophagy in multiple tissues [43].
    • Sleep patterns: sleep deprivation or abnormalities can negatively impact autophagy regulation [43].
ModulatorClassEffect on AutophagyMechanism/Pathway
mTORKinaseInhibitsNutrient-sensing/signalling [37,38]
AMPKKinaseActivatesEnergy-sensing [37,38]
RapamycinDrugActivatesmTOR inhibition [37,40]
ChloroquineDrugInhibitsBlocks lysosomal fusion [15,39]
Caloric RestrictionLifestyleActivatesmTOR/AMPK pathways [43]
MetforminDrugActivatesAMPK activation [37]
Insulin/IGF-1HormoneInhibitsmTOR activation [39]
GlucagonHormoneActivatesPromotes autophagy [15]
HypoxiaEnvironmentActivatesStress Response [15.39]
Table 4. Examples of Modulators

Autophagy is finely tuned by a network of nutrient sensors, kinases, hormones, stress signals, transcription factors, drugs, and lifestyle choices. The proper balance of these modulators ensures cellular health, and their dysregulation is implicated in many diseases. Modulating autophagy through genetic, pharmacological, or lifestyle interventions holds significant promise for metabolic, neurogenerative, and age-related conditions [15,37,43]

Clinical Implications of Autophagy

  1. Cancer
    • Tumor Suppresion and Progression: Autophagy can prevent early tumor development by clearing damaged organelles and proteins, reducing DNA errors. However, in established cancers, autophagy may help tumor cells survive stress, facilitate resistance to therapies, and promote growth [44-46].
    • Therapeutic Targeting: Autophagy inhibitors (like hydroxychloroquine) are being tested in clinical trials, especially in combination with other cancer treatments- though their benefits may depend on cancer type, stage and genetic background [45-47].
  2. Neurogenerative Diseases
    • Protein Aggregate Clearance: Defective autophagy is implicated in metabolic syndrome, diabetes, and premature aging, Enhancing autophagy may help restore cellular health and metabolic balance [46,48].
    • Therapeutic Potential: Autophagy is critical in defending against infections and balancing immune responses. Defects may increase infection risk and contribute to autoimmune and inflammatory disease.
  3. Metabolic, Cardiovascular, and Infectious Diseases
    • Metabolic and Aging Disorder: Defective autophagy is implicated in metabolic syndrome, diabetes, and premature aging. Enhancing autophagy may help restore cellular health and metabolic balance [46,48].
    • Infections and Immunity: Autophagy is critical in defending against infections and balancing immune response. Defects may increase infection risk and contribute to autoimmune and inflammatory disease [46,49].
  4. Gastrointestinal and Inflammatory Disease
    • Digestive Health: autophagy supports intestinal barrier function, regulates inflammation and is involved in the response to diseases like inflammatory bowel disease (IBD). modulating autophagy might help control chronic gut inflammation and tissue damage [50].
  5. Personalized and Precision Medicine
    • Genetic Variants: certain genetic variants of autophagy-related genes can affect drug response and disease susceptibility, underscoring the importance of genotype-guided approaches in therapy [51].

Future Directions

Recent advances have significantly enhanced our understanding of autophagy’s complex role in health and disease. However, several challenges remain:

  1. The context-dependent nature of autophagy, with both insufficient and excessive activation potentially causing harm, necessitates careful calibration of interventions.
  2. The tissue-specific regulation and effects of autophagy complicate therapeutic development.
  3. Translating findings from model organisms to humans requires consideration of species differences [52].

Future research should focus on developing methods to assess autophagy in humans non-invasively, enabling personalized interventions. Additionally, more selective modulators targeting specific autophagy pathways or tissues could overcome the limitations of current broad-spectrum approaches.

Area/DiseaseClinical ImplicationsFuture Directions
CancerDual role: tumor suppression & survival aid [44,45]Disease- specific inhibitors, combo therapies [45]
NeurodegenerationAggregate clearance, slowed progression [46,48]Enhancers for proteinopathies
Metabolic/AgingImprove metabolism, slow aging [46,48]Personalized modulation
Inflammatory/AutoimmuneControl inflammation, tissue protection [49,50]Gut-targeted autophagy therapies
Infectious DiseasesImmune defense, pathogen clearance [46,49]Adjuvants for infection control
Table 5. Clinical implications & Future Directions

Conclusion

In conclusion, autophagy represents a fundamental cellular process with far-reaching implications for health, disease prevention, and longevity. Its regulation by metabolic signals positions it at the intersection of cellular metabolism and homeostasis. Maintaining proper autophagic function through balanced metabolic signalling may contribute to improved health outcomes and potentially extended health span. While pharmacological interventions targeting autophagy show promise, dietary and lifestyle approaches that naturally modulate autophagy may offer safer alternatives by working through endogenous regulatory mechanisms.

As research in this field continues to evolve, a deeper understanding of autophagy’s role in specific tissues and disease states will likely yield more targeted and effective interventions. The goal should be to harness the beneficial aspects of autophagy while maintaining the essential balance between anabolic and catabolic processes that characterizes healthy cellular function.

References

  1. Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic Control of Autophagy. Cell. 2014 Dec;159(6):1263–76.
  2. Lin P, Chu M, Liu H. Autophagy and metabolism. The Kaohsiung Journal of Medical Sciences. 2020 Oct 5;37(1):12–9.
  3. Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. The Journal of Pathology [Internet]. 2010 Feb 3;221(1):3–12. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990190/
  4. Overview of autophagy | Abcam [Internet]. Abcam.com. 2025. Available from: https://www.abcam.com/en-us/technical-resources/pathways/autophagy-an-overview
  5. Gatica D, Chiong M, Lavandero S, Klionsky DJ. Molecular Mechanisms of Autophagy in the Cardiovascular System. Circulation Research. 2015 Jan 30;116(3):456–67.
  6. Yu L, Chen Y, Tooze SA. Autophagy pathway: Cellular and molecular mechanisms. Autophagy. 2017 Dec 31;14(2):207–15.
  7. Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: Regulator of cell death. Cell Death & Disease [Internet]. 2023 Oct 4;14(10):648. Available from: https://pubmed.ncbi.nlm.nih.gov/37794028/
  8. Badadani M. Autophagy Mechanism, Regulation, Functions, and Disorders. ISRN Cell Biology. 2012 Sep 6;2012:1–11.
  9. Czaja MJ. Functions of Autophagy in Hepatic and Pancreatic Physiology and Disease. Gastroenterology. 2011 Jun;140(7):1895–908.
  10. Kitada M, Koya D. Autophagy in metabolic disease and ageing. Nature Reviews Endocrinology [Internet]. 2021 Nov 1;17(11):647–61. Available from: https://pubmed.ncbi.nlm.nih.gov/34508250/
  11. News-Medical. Autophagy Functions [Internet]. News-Medical.net. 2011. Available from: https://www.news-medical.net/health/Autophagy-Functions.aspx
  12. Rocchi A, He C. Emerging roles of autophagy in metabolism and metabolic disorders. Frontiers in Biology. 2015 Mar 30;10(2):154–64.
  13. Levine B, Kroemer G. Biological Functions of Autophagy Genes: A Disease Perspective. Cell [Internet]. 2019 Jan;176(1-2):11–42. Available from: https://www.cell.com/cell/fulltext/S0092-8674(18)31260-1?rss=yes
  14. Boya P, Reggiori F, Codogno P. Emerging regulation and functions of autophagy. Nature Cell Biology [Internet]. 2013 Jul 1;15(7):713–20. Available from: https://www.nature.com/articles/ncb2788
  15. He C, Klionsky DJ. Regulation Mechanisms and Signaling Pathways of Autophagy. Annual Review of Genetics. 2009 Dec;43(1):67–93.
  16. Cao W, Li J, Yang K, Cao D. An overview of autophagy: Mechanism, regulation and research progress. Bulletin du Cancer. 2021 Mar;108(3):304–22.
  17. Lahiri V, Hawkins WD, Klionsky DJ. Watch What You (Self-) Eat: Autophagic Mechanisms that Modulate Metabolism. Cell Metabolism [Internet]. 2019 Apr;29(4):803–26. Available from: https://www.cell.com/cell-metabolism/pdf/S1550-4131(19)30131-7.pdf
  18. YANG Y, LIANG Z, GU Z, QIN Z. Molecular mechanism and regulation of autophagy1. Acta Pharmacologica Sinica. 2005 Dec;26(12):1421–34.
  19. Hardie DG. AMP-activated protein kinase–an energy sensor that regulates all aspects of cell function. Genes & Development. 2011 Sep 15;25(18):1895–908.
  20. ‌Ferhat M, Funai K, Boudina S. Autophagy in Adipose Tissue Physiology and Pathophysiology. Antioxidants & Redox Signaling. 2019 Aug 20;31(6):487–501.
  21. Khan F, Khan H, Khan A, Yamasaki M, Moustaid-Moussa N, Al-Harrasi A, et al. Autophagy in adipogenesis: Molecular mechanisms and regulation by bioactive compounds. Biomedicine & Pharmacotherapy. 2022 Nov;155:113715.
  22. 1Clemente-Postigo M, Tinahones A, El Bekay R, Malagón MM, Tinahones FJ. The Role of Autophagy in White Adipose Tissue Function: Implications for Metabolic Health. Metabolites [Internet]. 2020 Apr 30 [cited 2021 Aug 29];10(5). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281383/
  23. Jakubek P, Pakula B, Rossmeisl M, Pinton P, Rimessi A, Wieckowski MR. Autophagy alterations in obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease: the evidence from human studies. Internal and Emergency Medicine. 2024 Jul 6;19(5):1473–91.
  24. Ju L, Han J, Zhang X, Deng Y, Yan H, Wang C, et al. Obesity-associated inflammation triggers an autophagy–lysosomal response in adipocytes and causes degradation of perilipin 1. Cell Death and Disease. 2019 Feb 11;10(2).
  25. Al-kuraishy HM, Jabir MS, Al-Gareeb AI, Klionsky DJ, Albuhadily AK. Dysregulation of pancreatic β-cell autophagy and the risk of type 2 diabetes. Autophagy. 2024 Jun 14;1–12.
  26. Friuli M, Sepe C, Panza E, Travelli C, Paterniti I, Romano A. Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies? Frontiers in Pharmacology. 2024 Jun 4;15.
  27. Pabon MA, Ma KC, Choi AMK. Autophagy and Obesity-Related Lung Disease. American Journal of Respiratory Cell and Molecular Biology. 2016 May;54(5):636–46.
  28. Hansen M, Rubinsztein DC, Walker DW. Autophagy as a promoter of longevity: insights from model organisms. Nature reviews Molecular cell biology [Internet]. 2018 [cited 2019 Aug 5];19(9):579–93. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30006559
  29. Markaki M, Metaxakis A, Tavernarakis N. The Role of Autophagy in Aging. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging [Internet]. 2017 [cited 2025 Jul 22];123–38. Available from: https://tavernarakislab.gr/publications/20.pdf
  30. Nakamura S, Yoshimori T. Autophagy and Longevity. Molecules and Cells [Internet]. 2018 Jan 31;41(1):65–72. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792715/
  31. Kevser Taban Akça, İlknur Çınar Ayan, Sümeyra Çetinkaya, Ece Salihoğlu, İpek Süntar. Autophagic mechanisms in longevity intervention: role of natural active compounds. Expert Reviews in Molecular Medicine. 2023 Jan 1;25.
  32. Madeo F, Zimmermann A, Maiuri MC, Kroemer G. Essential role for autophagy in life span extension. Journal of Clinical Investigation. 2015 Jan 2;125(1):85–93.
  33. Morselli E, Galluzzi L, Kepp O, Criollo A, Maiuri MC, Tavernarakis N, et al. Autophagy mediates pharmacological lifespan extension by spermidineand resveratrol. Aging. 2009 Dec 23;1(12):961–70.
  34. Locatelli A, Cenci S. Autophagy and longevity: Evolutionary hints from hyper-longevous mammals. Frontiers in Endocrinology [Internet]. 2022 Dec 20 [cited 2024 Jan 24];13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807614/
  35. Aman Y, Schmauck-Medina T, Hansen M, Morimoto RI, Simon AK, Bjedov I, et al. Autophagy in healthy aging and disease. Nature Aging. 2021 Aug;1(8):634–50.
  36. Yeh CH, Shen ZQ, Wang TW, Kao CH, Teng YC, Yeh TK, et al. Hesperetin promotes longevity and delays aging via activation of Cisd2 in naturally aged mice. Journal of Biomedical Science. 2022 Jul 24;29(1).
  37. Panda PK, Fahrner A, Vats S, Seranova E, Sharma V, Chipara M, et al. Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases. Frontiers in Cell and Developmental Biology. 2019 Mar 19;7.
  38. Parzych KR, Klionsky DJ. An Overview of Autophagy: Morphology, Mechanism, and Regulation. Antioxidants & Redox Signaling. 2014 Jan 20;20(3):460–73.
  39. Badadani M. Autophagy Mechanism, Regulation, Functions, and Disorders. ISRN Cell Biology. 2012 Sep 6;2012:1–11.
  40. Fleming A, Noda T, Yoshimori T, Rubinsztein DC. Chemical modulators of autophagy as biological probes and potential therapeutics. Nature Chemical Biology [Internet]. 2011 Jan 1 [cited 2022 Mar 10];7(1):9–17. Available from: https://pubmed.ncbi.nlm.nih.gov/21164513/
  41. Lei Y, Klionsky DJ. Transcriptional regulation of autophagy and its implications in human disease. Cell Death & Differentiation [Internet]. 2023 Apr 12;30(6):1416–29. Available from: https://www.nature.com/articles/s41418-023-01162-9.pdf
  42. Yin Z, Pascual C, Klionsky D. Autophagy: machinery and regulation. Microbial Cell. 2016 Dec 5;3(12):588–96.
  43. Ortega MA, Fraile-Martinez O, de Leon-Oliva D, Boaru DL, Lopez-Gonzalez L, García-Montero C, et al. Autophagy in Its (Proper) Context: Molecular Basis, Biological Relevance, Pharmacological Modulation, and Lifestyle Medicine. International Journal of Biological Sciences [Internet]. 2024 Apr 22 [cited 2024 Jun 4];20(7):2532–54. Available from: https://www.ijbs.com/v20p2532.htm
  44. Cleveland Clinic. Autophagy: Definition, Process, Fasting & Signs [Internet]. Cleveland Clinic. 2022. Available from: https://my.clevelandclinic.org/health/articles/24058-autophagy
  45. Amaravadi RK, Kimmelman AC, Debnath J. Targeting Autophagy in Cancer: Recent Advances and Future Directions. Cancer Discovery. 2019 Aug 21;9(9):1167–81.
  46. Cheng Y, Ren X, Hait WN, Yang JM. Therapeutic Targeting of Autophagy in Disease: Biology and Pharmacology. Ma Q, editor. Pharmacological Reviews. 2013 Aug 13;65(4):1162–97.
  47. Ishaq M, Ojha R, Sharma AP, Singh SK. Autophagy in cancer: Recent advances and future directions. Seminars in Cancer Biology. 2020 Nov;66:171–81.
  48. Shabkhizan R, Haiaty S, Moslehian MS, Bazmani A, Sadeghsoltani F, Saghaei Bagheri H, et al. The Beneficial and Adverse Effects of Autophagic Response to Caloric Restriction and Fasting. Advances in Nutrition [Internet]. 2023 Jul 30;14(5):1211–25. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509423/
  49. Ge Y, Huang M, Yao Y. Autophagy and proinflammatory cytokines: Interactions and clinical implications. Cytokine & Growth Factor Reviews. 2018 Oct;43:38–46.
  50. Mukaddes Esrefoglu. Harnessing autophagy: A potential breakthrough in digestive disease treatment. World Journal of Gastroenterology [Internet]. 2024 Jun 25 [cited 2024 Sep 19];30(24):3036–43. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11230060/
  51. Yuan J, Zhang N, Yin L, Zhu H, Zhang L, Zhou L, et al. Clinical Implications of the Autophagy Core Gene Variations in Advanced Lung Adenocarcinoma Treated with Gefitinib. Scientific Reports [Internet]. 2017 Dec 13 [cited 2025 Jul 22];7(1). Available from: https://www.nature.com/articles/s41598-017-18165-5
  52. Shang J, Zhao F, Xie L, Wang Y, Li B, Jin C. Trends and future directions of autophagy in osteosarcoma: A bibliometric analysis. Open Medicine [Internet]. 2024 Jan 1 [cited 2025 Jul 22];19(1). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11627063/